Zynex, Inc. was founded by Thomas Sandgaard in 1996 to develop advanced electrotherapy technology that alleviates chronic pain and aids the recovery of patients affected by debilitating illnesses.
Through the dedication and hard work of our team, the company has established itself as a global leader in the manufacturing of electrotherapy devices for pain management, physical rehabilitation, neurological diagnosis, and cardiac monitoring.
We are dedicated to combating the opioid epidemic, and our NexWave device is a safe alternative to opioids for the management of intractable pain.
Zynex has been ranked 13th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2020 Technology Fast 500.